Implantation of the clinical-grade human neural stem cell line, CTX0E03, rescues the behavioral and pathological deficits in the quinolinic acid-lesioned rodent model of Huntington's disease. (2020)

First Author: Yoon Y
Attributed to:  Wellcome Trust MRC Cambridge Stem Cell Institute funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/stem.3191

PubMed Identifier: 32374064

Publication URI: http://europepmc.org/abstract/MED/32374064

Type: Journal Article/Review

Volume: 38

Parent Publication: Stem cells (Dayton, Ohio)

Issue: 8

ISSN: 1066-5099